Body Composition, Frailty, and Function in Rehabilitation (NCT06527742) | Clinical Trial Compass
RecruitingNot Applicable
Body Composition, Frailty, and Function in Rehabilitation
Singapore345 participantsStarted 2024-12-09
Plain-language summary
The investigators are investigating if body composition measures - in particular muscle mass, body fat, and something called the phase angle - are able to reliably predict functional outcomes for patients who are in an acute hospital for inpatient rehabilitation. The investigators also want to see if age and frailty affect these relationships.
Patients undergoing inpatient rehabilitation in our hospital will be monitored through a variety of frailty-specific tools, including strength and speed. The investigators will use a device called a body composition monitor (BCM) to record their body composition measurements. These will then be compared against their usual rehabilitation outcomes.
The investigators believe that there is a correlation between these measures and a patient's functional outcomes.
Who can participate
Age range
21 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. Transferred under the Rehabilitation Medicine service for post-acute rehabilitation
. Rehabilitation diagnosis of:
. Stroke with motor weakness (modified Rankin scale 1-5), or
. Deconditioning (from sepsis, post-ICU admission, heart failure, falls, musculoskeletal conditions with or without pain, or other conditions), or
. Pulmonary rehabilitation (with or with long-term oxygen therapy), or
. Lower limb amputees (transtibial or transfemoral)
. Medically stable
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
M-FIM
Timeframe: Baseline at recruitment, and upon discharge from the inpatient rehabilitation unit which is an average of 2 weeks later
. Able to understand English consent form or suitably-translated document, or have a family member/legally-authorised representative who is able to do so and willing to provide consent
Exclusion criteria
. Pacemaker or implantable defibrillator in-situ
. Medical devices or surgical implants that will interfere with BIA measurement per the manufacturer's guidelines
. Abnormal fluid status (overloaded or depleted) at the point of screening
. Cognitive or physical inability to tolerate sitting/lying still for 2mins (for BIA measurement)